Zhenzhen Si

No. 199 Donggang West Road
Lanzhou, 730000, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 11 publications

Targeting CDK4 with repurposing perphenazine inhibited the growth of gastric cancer AGS and HGC27 cells by arresting cell cycle.

Targeting CDK4 with repurposing perphenazine inhibited the growth of gastric cancer AGS and HGC27 cells by arresting cell cycle.

Journal: Biochemical pharmacology

Published: March 24, 2026

Antihistamine drug terfenadine suppressed the cycle progression of gastric cancer cells by targeting PI3K/AKT/mTOR signaling.

Antihistamine drug terfenadine suppressed the cycle progression of gastric cancer cells by targeting PI3K/AKT/mTOR signaling.

Journal: Frontiers in pharmacology

Published: October 12, 2025

Embryonic sheep placenta alleviates muscle-fat wasting symptoms and improves gut microbiome dysbiosis in cachexia mice.

Embryonic sheep placenta alleviates muscle-fat wasting symptoms and improves gut microbiome dysbiosis in cachexia mice.

Journal: Biochemistry and biophysics reports

Published: August 31, 2025

Prochlorperazine dimaleate elicits antiproliferative activity of gastric cancer cells via inhibiting the PI3K/AKT/mTOR signaling pathway.

Prochlorperazine dimaleate elicits antiproliferative activity of gastric cancer cells via inhibiting the PI3K/AKT/mTOR signaling pathway.

Journal: Genes & diseases

Published: August 13, 2025

Camptothecin 20(S)-sulfonyl amidine derivative inhibits gastric cancer cell proliferation by targeting topoisomerase I to trigger the DNA damage-apoptosis cascade.

Camptothecin 20(S)-sulfonyl amidine derivative inhibits gastric cancer cell proliferation by targeting topoisomerase I to trigger the DNA damage-apoptosis cascade.

Journal: Bioorganic chemistry

Published: August 11, 2025

Lactobacillus-derived exopolysaccharide enhances localized cisplatin chemotherapy by modulating gut microbiota in colorectal cancer.

Lactobacillus-derived exopolysaccharide enhances localized cisplatin chemotherapy by modulating gut microbiota in colorectal cancer.

Journal: International journal of biological macromolecules

Published: July 29, 2025

Sorafenib and ponatinib as effective inhibitors of Fusobacterium nucleatum FtsZ: An in silico and in vitro study.

Sorafenib and ponatinib as effective inhibitors of Fusobacterium nucleatum FtsZ: An in silico and in vitro study.

Journal: International journal of biological macromolecules

Published: June 27, 2025

Antitumor activity of XSJ81, a 20-sulfonated camptothecin derivative, targeting topoisomerase I against ampullary carcinoma.

Antitumor activity of XSJ81, a 20-sulfonated camptothecin derivative, targeting topoisomerase I against ampullary carcinoma.

Journal: Bioorganic chemistry

Published: May 23, 2025

Gut Microbiota Mediate Periampullary Cancer Through Extracellular Matrix Proteins: A Causal Relationship Study.

Gut Microbiota Mediate Periampullary Cancer Through Extracellular Matrix Proteins: A Causal Relationship Study.

Journal: IET systems biology

Published: May 18, 2025

Tailoring a Functional Synthetic Microbial Community Alleviates Fusobacterium nucleatum-infected Colorectal Cancer via Ecological Control.

Tailoring a Functional Synthetic Microbial Community Alleviates Fusobacterium nucleatum-infected Colorectal Cancer via Ecological Control.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Published: November 03, 2024

Identification of 7-aminourea or 7-aminothiourea derivatives of camptothecin as selective topoisomerase I inhibitors with anti-colorectal cancer activities.

Identification of 7-aminourea or 7-aminothiourea derivatives of camptothecin as selective topoisomerase I inhibitors with anti-colorectal cancer activities.

Journal: Bioorganic chemistry

Published: April 01, 2024

Showing 1-11 of 11

Last Updated: 09/26/2026